BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29768356)

  • 21. Efficacy of neoadjuvant endocrine therapy in patients with poorly differentiated neuroendocrine carcinoma of the breast: A case report.
    Zhang Y; Liu C; Zheng C; Ren Q; Wang Q; Gao X; He Y; Wu J; Chen G; Li X; Ma Z
    Medicine (Baltimore); 2020 Oct; 99(43):e22652. PubMed ID: 33120755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letrozole in the extended adjuvant setting: MA.17.
    Goss PE
    Breast Cancer Res Treat; 2007; 105 Suppl 1(Suppl 1):45-53. PubMed ID: 17912635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.
    Ingle JN; Tu D; Pater JL; Muss HB; Martino S; Robert NJ; Piccart MJ; Castiglione M; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Goss PE
    Ann Oncol; 2008 May; 19(5):877-82. PubMed ID: 18332043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic chemotherapy and tamoxifen induced regression of choroidal metastasis from a breast carcinoma in a male.
    Shome D; Jayadev C; Gadgil D; Natarajan S; Jain V
    Indian J Ophthalmol; 2007; 55(6):475-7. PubMed ID: 17951913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case of endobronchial metastasis from breast cancer accompanied with Cunninghamella bertholletiae tracheobronchial mycetoma.
    Uno K; Hishiya N; Matsuda M; Kai Y; Amano M; Nakamura A; Tohjyo T; Kawaguchi T; Nakano R; Yano H; Kasahara K; Mikasa K
    J Infect Chemother; 2019 Dec; 25(12):1065-1069. PubMed ID: 31227382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A Case of Recurrent Breast Cancer with Multiple Bone Metastasis Effectively Treated by CDK4/6 Inhibitor in Addition to Aromatase Inhibitor].
    Satoh E; Hara M; Uehira D; Yonekura K; Murakata A; Ohinata R; Toyofuku Y; Tanami H; Osanai T; Sugano N; Sakoma T
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1491-1493. PubMed ID: 36733112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea.
    Beom SH; Oh J; Kim TY; Lee KH; Yang Y; Suh KJ; Moon HG; Han SW; Oh DY; Han W; Kim TY; Noh DY; Im SA
    Cancer Res Treat; 2017 Apr; 49(2):454-463. PubMed ID: 27554482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultra wide-field imaging of choroidal metastasis secondary to primary breast cancer.
    Coffee RE; Jain A; McCannel TA
    Semin Ophthalmol; 2009; 24(1):34-6. PubMed ID: 19241290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial.
    Olson JA; Budd GT; Carey LA; Harris LA; Esserman LJ; Fleming GF; Marcom PK; Leight GS; Giuntoli T; Commean P; Bae K; Luo J; Ellis MJ
    J Am Coll Surg; 2009 May; 208(5):906-14; discussion 915-6. PubMed ID: 19476859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
    Finn RS; Crown JP; Lang I; Boer K; Bondarenko IM; Kulyk SO; Ettl J; Patel R; Pinter T; Schmidt M; Shparyk Y; Thummala AR; Voytko NL; Fowst C; Huang X; Kim ST; Randolph S; Slamon DJ
    Lancet Oncol; 2015 Jan; 16(1):25-35. PubMed ID: 25524798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of advanced breast carcinoma effectively treated postoperatively with tegafur-uracil].
    Enomoto K; Sakurai K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2366-8. PubMed ID: 24394114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
    Paolino G; Panetta C; Didona D; Donati M; Donati P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of early adjuvant aromatase inhibitor therapy: contributions from the BIG 1-98 letrozole trial.
    Forbes JF
    Semin Oncol; 2006 Apr; 33(2 Suppl 7):S2-7. PubMed ID: 16730270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two cases with long-term disease-free survival after resection and radiotherapy for solitary brain metastasis from breast cancer with extensive nodal metastases.
    Saisho S; Takashima S; Ohsumi S; Saeki H; Aogi K; Saeki T; Mandai K; Iwata S; Takeda T
    Breast Cancer; 2005; 12(3):221-5. PubMed ID: 16110293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
    Turashvili G; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
    BMC Cancer; 2018 Jan; 18(1):42. PubMed ID: 29304773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial.
    Goss PE
    Semin Oncol; 2006 Apr; 33(2 Suppl 7):S8-12. PubMed ID: 16730271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the BIG results: Insights from the BIG 1-98 trial analyses.
    Wardley AM
    Adv Ther; 2008 Dec; 25(12):1257-75. PubMed ID: 19096768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An elderly patient with advanced breast cancer who responded to treatment with letrozole-a case report].
    Yoneyama K; Nakamura H
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2565-7. PubMed ID: 24335371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial.
    Wu W; Deng H; Rao N; You N; Yang Y; Cao M; Liu J
    Trials; 2017 Oct; 18(1):497. PubMed ID: 29070044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial.
    Ingle JN; Tu D; Pater JL; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Goss PE
    Breast Cancer Res Treat; 2006 Oct; 99(3):295-300. PubMed ID: 16541302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.